Gürkan, SelamiGür, ÖzcanGür Özkaramanlı, DemetArar, Makbule CavidanEge, Turan2022-05-112022-05-1120162149-2980https://app.trdizin.gov.tr/makale/TWpBM01UUTNOdz09https://hdl.handle.net/20.500.11776/5536Elli bir yaşında mitral yetmezlik tanısı ile cerrahi tedavi için yatırılan bir hastayı sunduk. Dört yıl önce primer antifosfolipid tanısı almış ve trombositopeni hikayesi mevcut. Postoperatif titiz antikoagülan tedavi ile mitral kapak başarılı bir şekilde replase edildi ve postoperatif dönem olaysız geçti. Antifosfolipid sendromlu hastalarda kardiyak cerrahide yüksek mortalite ve morbidite oranları bildirilmiştir. Postoperatif dönemde hemen antikoagülan tedavinin başlanması trombozun önlenmesi açısından çok önemlidir.We report a 51-year-old patient who was diagnosed with mitral insuffi ciency and was admitted to our hospital for surgical treatment. The patient was diagnosed with primary antiphospholipid syndrome (PAPS) before 4 years and had a history of thrombocytopenia. Mitral valve replacement was successfully performed with postoperative strict anticoagulant therapy, and the postoperative course was uneventful. Cardiac surgery in APS patients has been associated with high morbidity and mortality. Therefore, it is very important to initiate anticoagulant therapy immediately after the operation to prevent thrombosis.eninfo:eu-repo/semantics/openAccessCerrahiSuccessful Replacement of Mitral Valve in a Patient with Antiphospholipid SyndromeAntifosfolipid Sendromlu Bir Hastada Başarılı Mitral Kapak ReplasmanıArticle1914041TWpBM01UUTNOdz09